Clinical Trials Browser

Phase 2 × Down Syndrome × hydrocortisone hemisuccinate × Clear all

NCT04546399 2025-09-10

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 2 Recruiting

Burkitt Lymphoma, Down Syndrome